Profile
Thomas Schulze is the founder of FundaMental Pharma GmbH, a company founded in 2016, where he currently holds the title of Non-Executive Director.
He previously held the position of Chief Executive Officer at Avontec GmbH from 2009 to 2010.
Dr. Schulze also worked at Bayer AG as a Principal and at november AG as Chief Operating Officer.
Additionally, he held the position of Principal at Bayer Yakuhin Ltd. Dr. Schulze obtained a doctorate degree from Freie Universität Berlin.
Thomas Schulze active positions
| Companies | Position | Start |
|---|---|---|
FundaMental Pharma GmbH
FundaMental Pharma GmbH Pharmaceuticals: MajorHealth Technology Develops drugs for neuro protective molecular spacers | Founder | 2015-12-31 |
Former positions of Thomas Schulze
| Companies | Position | End |
|---|---|---|
Avontec GmbH
Avontec GmbH Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutic treatments for inflammatory disease | President | 2010-04-18 |
Bayer Yakuhin Ltd.
Bayer Yakuhin Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and diagnostic substances | Corporate Officer/Principal | - |
| BAYER AG | Corporate Officer/Principal | - |
november AG
november AG Financial ConglomeratesFinance Operates as an investment holding company | Chief Operating Officer | - |
Training of Thomas Schulze
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Bayer AG
Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
november AG
november AG Financial ConglomeratesFinance Operates as an investment holding company | Finance |
Bayer Yakuhin Ltd.
Bayer Yakuhin Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and diagnostic substances | Health Technology |
Avontec GmbH
Avontec GmbH Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutic treatments for inflammatory disease | Health Technology |
Freie Universität Berlin
Freie Universität Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FundaMental Pharma GmbH
FundaMental Pharma GmbH Pharmaceuticals: MajorHealth Technology Develops drugs for neuro protective molecular spacers | Health Technology |
- Stock Market
- Insiders
- Thomas Schulze
















